Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02349867
Title Gemcitabine Hydrochloride, Nab-Paclitaxel, Radiation Therapy, Sorafenib Tosylate,Vorinostat in Treating Previously Untreated Pancreatic Cancer Patients
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Virginia Commonwealth University, National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.